Ibsrela (tenapanor)

Ardelyx wins FDA approval for Xphozah, a new drug for chronic kidney disease

Ardelyx’s perseverance pays off as the FDA grants approval for its groundbreaking medication, Xphozah (tenapanor), marking the third attempt as ...